Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-6950 (gemilukast) vs pranlukast in asthma
jRCT2080222716Phase 2
- Sponsor
- Ono Pharmaceutical
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of gemilukast in asthma (2 arms), sponsored by Ono Pharmaceutical.
02
Drugs
gemilukast
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2080222716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222716.